fourth double-digit net fourth quarter to covering financial you, you the Good joining quarter strong for report am results. was produced I delighted Tom. full solid our the conference adjusted and XXXX morning income and growth that PRA quarter which and growth. for Thank call thank another year revenue
continued to We business a when net increased book-to-bill new in or $XXX times our fourth of awards new revenue, quarter XXXX. awards million our X.X backlog. consecutive also X% We growth business net compared of net to book-to-bill and see to Net quarter our had strong than greater run of the new approximately revenue. equal X.X business of continuing times representing
net business with a billion representing For times. of record book-to-bill of new net growth of XXXX, full and XX% year awards, $X.X X.XX a level of
of and addition The our approximately approximately business increasing have discussed, previously new revenue XX% a the $X.X XXX, excludes awards of net and billion. ASC backlog resulted we year-over-year, finishing new our our and in excludes excludes reimbursement our awards has revenue Data on Solutions sequential As from revenue of calculation basis book-to-bill X% impact ratio adopting segment. at
year. previous quarters previously our disclosed, year-over-year and which million a coming Adjusted diluted net quarter fourth over gross Adjusted exchange of coming income and adoption was represents at the our The segment. impact be awards of share rates. consistent approximately the include And awards XX% biotech was period approximately was approximately sector fourth versus new addition, approximately currency our the from XX% $XX at we've XX% XX% backlog. exclude $X.XX increase business per with XXXX. continues an Data basis. Revenue with As XX% we and the of diversity from approximately the reimbursement not a an pass-throughs foreign rates in was our excluding exchange million, the for foreign investigator same increase pharmaceutical X% actual revenue Revenue fourth of net ASC quarter new of revenues XXX backlog of and of to on increase XX% does for Solutions from $XXX approximately income sector. year-over-year actual the quarter last constant the approximately
clients diversified client continues and XX% representing largest approximately the Our our five impact exclude be for the X% adopting client ASC quarter total of of top Both base total revenue to our well of representing with approximately metrics XXX. revenue.
representing XX% XXXX full full reimbursement XXXX constant overall revenue drove the growth. of XXX and adoption to basis. currency approximately was of revenue of foreign actual year results a currency Our and improved reported constant excludes foreign growth impact We revenue year continue XX% our and consistent at basis. financial a trend XX% both $X.X our margins. rates on solid on and approximately We operating approximately exchange exchange strong at actual billion currency our acquisitions of revenue the ASC rates of Organic growth year-over-year which and growth
long-term During well and are of we believe XXXX, We offer services our a Mike in Due performance sustainable we a share call. share. will additional details believe guidance foundation offerings. we and in provide adjusted wide per are per XXXX business our enhanced our prevail we earnings $X.XX XXXX that clients. the between anticipating XXXX to growth solid about made per positioned to that us variety diluted established significant $X.XX later our to in and service our will allow investments to have a share and
studies I activity items. impact that of take provide the Symphony just stages a business; XXXX, on would of about to to heading update business Pharma moment of our the our were integration XXXX on of the many of brief and into industry canceled you a During like these the raised questions M&A each
past I've result the as of up XXXX. replacement have Regarding had reprioritized of running duration canceled previously, as a half been and and latter studies. the the And mentioned in but and a replaced subsequently we've a replaced pipeline client our as the studies studies. since and our canceled The these longer were have than mentioned then original similar value, the studies were
on have impact transaction studies of X, closed China currently Takeda are forward partnership are the Takeda to heads As look of we XXXX. our the and in transaction We year we running our closing future. this the and with anticipate relationship. January you an are transaction to for impact it don't We aware, of the about Takeda will into as continuing four our new optimistic in have business the
have our Solutions to Data am that MPD now integration our pleased I plans position offerings. finalized and our segment, Regarding a in complete the we we and are expand in service
to Health sorry like clients the commitment continued and saw seasonality for anticipated, I forecast unusual and to our -- this entire in for usual As we able year. our staff are In we their would the closing, our business thank meet Sciences. to PRA the
financial and Colin. believe are go like now to our financial Bonello well strong and hand call everyone. our full Officer with morning you, Bonello XXXX. I will through positioned we Mike to for Good Chief delighted who results are year Financial results We the Thank more would quarterly in detail. over our Mike
our million consolidated fourth revenue the quarter XXXX, actual fourth basis. revenue the We approximately reported fourth recorded of quarter the for for of guidance, $X foreign negatively exchange of to of fluctuations third by quarter at was our grew lower-than-forecasted revenue million foreign XX% quarter of revenue million XXXX constant of comparing and reported reimbursement For revenue rates and When compared XX.X% $XXX.X million. fourth $XXX.X a on currency currency impacted $X quarter XXXX. to
at of of approximately actuals actual came and Research foreign XXX of currency a for segment exchange was XXXX constant X.X% the of Our the Solutions fourth increased million revenue Revenue guidance X.X% Clinical and revenue, at for rates and a the adoption ASC by the XX%. segment while XX.X% on XXX in the assumed Data segment. for revenue $XX excluding $XXX.X impact reimbursement ASC Revenue basis. of quarter reimbursement million
Regarding small-to-midsized and segment, companies. biotechnology exclude for pharmaceutical we've Total line Data biotechnology pharmaceutical in from quarter XX% reimbursement what from XXXX. XXXX Solutions million by levels million our we derived companies companies, decrease of we concentration adoption million XX% in revenue XX% in in all and favorable from currency concentration are with our continue to increase our the XXXX, service the staffing $XXX.X XX% metrics ensure which seen direct of $X.X quarters. from revenue $X.X of to the labor revenue companies, Solutions Data and in Research the increase related foreign was appropriate was direct our $XXX.X The from in costs fourth an quarter cost other fourth large a XXX impact segment, of of of compared large and quarter These were previous in million to primarily costs exchange fourth as offset in Clinical related of rates, an segment. ASC
of of increase Excluding of the or revenue XXXX, the the of XX fourth costs primarily due of direct is and in earlier were XXXX. the percentage costs XX.X% quarter reimbursement expenses decrease exchange revenue, staff. ASC fourth compared our service in quarter fluctuations of were service SG&A an adoption of XX.X% The direct to favorable as revenue XX.X% utilization in XXX discussed million $XX.X and rate a of to currency in revenue. -- impact
third of compared The for of expenses XXXX. impact the plan expense consistent and in related stock SG&A XXXX to quarter compensation XXXX. percentage of slight quarter our quarter revenue the fourth stock-based service saw XX.X% and primarily our in the year. reimbursement an to in trend the the is the The current in adoption ASC is fourth of initiation of during related adoption primarily purchase increase stock-based compensation revenue program the of for Excluding annual as the of XXX increase we the is increase grant to of with employee a and
quarter period-to-period in net fourth per which Adjusted year. $X.XX Both quarter the fourth related earn-out items to amounts to last $X.X in of quarter the income, During diluted compared million our to of related changes fourth our XXXX. results correspond per excludes $X.XX expenses with incurred were XXXX, to grew the changes share to in year-over-year compared associated net necessarily increased quarter million, of XXXX. XX.X% transaction fourth operating value fair in XXXX, $XX.X we certain does of primarily fluctuation of XX% in same as per Adjusted acquisitions. liabilities quarter share $XX.X income of during share from to million the not the
the the $XXX.X operations at XX% exchange months XXXX, reimbursement XXX of our and XXXX, exchange million the December ended approximately year Cash for three basis. ended for ASC actual grew Revenue December XXX operations adoption XX% $X.X on foreign with the XXXX. at the XX% and excluding to to and in months was $X.X the excluding ASC XX, December provided cash of XX, of compared by provided revenue, million months year. million of comparable three prior impact XX and the revenue consolidated currency billion approximately constant rates rates compared $XXX.X XX, of the reimbursement the of impact We increased adoption finished revenues a by For foreign currency actual a ended revenue on basis. constant XX%
For was increase XX, million, for operating cash in months provided ended ended our XXXX, December the and was XXXX. by XX the in a capital. $XXX.X performance cash XX The flow operations million XX, of working to December $XXX.X of operational optimization result an increase compared months
three net ended Capital December XX, XX December million December for for months to XX, sales were compared XXXX, XXXX. the expenditures months to expenditures at at XX, December were the day’s for were million $XX days December ended XXXX, $XX.X $XX.X three days December XXXX. $XX.X XX ended XXXX. XX, for million XXXX, XX, XX months ended compared the months Capital to Our the outstanding XX, XX compared million
support expansion continue Our to to reflect of information capital and the investment our growth. infrastructure expenditures in technology our our
was Our million compared total cash at was December and to debt XXXX. billion which the cash quarter, held at subs. equivalents million XX, December of of $X.XX balance end Net less our fourth $XXX.X $XX.X outstanding as foreign by debt cash XXXX was the $XXX.X million, XX, defined at
additional payments During the XXXX, made million. we of voluntary fourth of $XXX quarter principal
During on long-term were debt million. total XXXX, payments $XXX principal
of denominated XX, is ASC quarters and which December with Regarding impact reimbursement adoption in consistent our of XXXX XX% at with currency prior XXX dollars, of and denominated U.S. total of the the in expenses U.S. revenue concentration XXXX, and levels. XX% revenue were dollars consistent were our excluding
hedged. naturally be to continues exposure euro Our
in exposure X% our was of to GBP. than the less we've of As we have X% GBP, as prior movements quarters, discussed in GBP, our in denominated denominated are expenses revenue while in
at look reduce exposure. ways to continue We this to
and $X.XX $X.X to are XX%. basis, revenues growth as-reported currency we're XX%. net $X.XXX an On revenues XXX currency XXXX, and representing for guidance ASC to constant representing between and X% billion Turning of our of growth to as-reported and we between billion estimating X% $X.XX billion, estimating constant billion,
that anticipate Cuts $X.XX will XX%, per share. share expected We between be changes incorporates $X.XX anticipating share and and are the annual adjusted We from Act. per and diluted share earnings Jobs earnings GAAP tax U.S. $X.XX diluted Tax rate our between the per which $X.XX approximately income per and effective
Our estimate or Tax or of our guidance are this effective in rate the U.S. Cuts changes what is if distribution and from related analysis geographical we've estimated interpretation Act. may pre-tax with Jobs issued differ from the the there to earnings changes additional if
XXXX Regarding of representing X%. X% guidance, as-reported and growth XXX and to to QX revenues $XXX X% $XXX are constant between revenues X% and $XXX between X% of estimating X%. and ASC representing to $XXX growth to growth of we're we basis, X% On of X% million estimating currency constant currency an million, million, as-reported growth million
first on XX.X% the the constant organic Solutions excluding reminder, of segment a Data on of basis revenue we reported currency As as-reported revenue reimbursement in quarter XXX and in XX.X% an XXXX. growth a basis ASC
earnings in in share taxes benefits GAAP between expect $X.XX of to seasonality with $X.XX $X.XX are QX the expenses, such are and our with are earnings This per our Data $X.XX line to per guidance, Solutions Like employee of and growth our and per rate guidance ensure diluted We guidance payroll per share segment tax and income full expenses as, around sequential the share we years, including expectations be impact related recurring meetings. includes incurred we our and earnings that expectations. effective the between Consistent quarter internal to organizational prior first and impact quarter anticipating XX%. year share. adjusted
of rate XX, our other guidance X.XX. exchange exchange currency XXXX. as All euro are a rates and pound British exchange a of X.XX rate assumes of Finally, foreign January
take open evaluate questions. for the the determining prepared rate now when XX affiliation and consistent for and asking process to Our Operator, be your with you we'd used expected question. where exchange prior provide line Please rates That to bank we questions. for concludes is now next happy years movements resources remarks, a months. several your name our may
